UFP Technologies (UFPT) is a specialized contract manufacturer focused on medical devices and engineered foam/plastic products that has delivered strong recent revenue and earnings growth through organic expansion and acquisitions, supported by favorable analyst price targets but with mixed consensus ratings and exposure to cyclical industrial markets.
Links for more information: Yahoo Finance UFPT Quote & History | Historical Data | MarketBeat Performance
| Period | UFPT Return (Fact) | S&P 500 Return (Fact) |
|---|---|---|
| YTD (as of ~Aug 2026) | 45.25% | 11.68% |
| 1-Year | 42.53% | 20.77% |
| 3-Year | 76.81% | 70.72% |
| 5-Year | 384.60% | 73.64% |
Fact: UFPT has significantly outperformed the S&P 500 over the reported periods, with particularly strong 5-year returns.
Interpretation: This outperformance may reflect successful execution in the high-growth MedTech segment and multiple acquisitions expanding capabilities.
Uncertainty: Returns are trailing total returns as of approximately August 4, 2026; future performance is uncertain and subject to market conditions.
| Metric | Value (Fact) | Notes |
|---|---|---|
| Revenue (TTM) | $608.85 million | Full year basis |
| Net Income (TTM) | $68.62 million | |
| Diluted EPS (TTM) | $8.79 | |
| Profit Margin | 11.27% | |
| ROA (TTM) | 8.81% | |
| ROE (TTM) | 17.17% | |
| Price/Sales (TTM) | 3.27 | Valuation |
| Price/Book (MRQ) | 4.49 | |
| Total Debt/Equity (MRQ) | 35.56% | Leverage |
| Levered Free Cash Flow (TTM) | $53.57 million |
Fact: Q2 2026 (ended June 30, 2026) reported record results with net sales of $174.0 million (+15.1% YoY from $151.2 million), net income $20.9 million (+21.4% YoY), GAAP EPS $2.68, adjusted EPS $2.92 (beat consensus $2.56).
Fact: Six-month 2026 sales $328.2 million; adjusted EPS $5.39.
Limitation/Assumption: Financial data sourced primarily from Yahoo Finance and company press releases as of early August 2026; TTM figures aggregate latest four quarters and may include one-time items. Exact quarterly breakdowns beyond Q2 2026 not fully detailed in public summaries. No dividend (yield N/A).
Links for more information: Yahoo Finance Analyst Estimates | MarketBeat Consensus | Benzinga Ratings
| Source/Date | Consensus Rating | Avg. Price Target | High | Low |
|---|---|---|---|---|
| Yahoo Finance (recent) | Strong Buy (mixed views) | $324.50 | $360.00 | $289.00 |
| MarketBeat | Hold (score 2.33/5) | $289.00 | $289.00 | $289.00 |
| Benzinga (4 analysts) | N/A | $272.00 | $289.00 (Lake Street) | N/A |
Fact: Latest specific rating (Aug 6, 2025): Lake Street maintains Buy, raises target from $252 to $289.
Interpretation: Targets imply potential upside from recent trading levels, reflecting optimism on MedTech growth, though consensus varies between Hold and Strong Buy across platforms.
Uncertainty: Analyst ratings and targets change frequently; data reflects snapshots from different dates/sources and may not capture the most recent revisions. Number of covering analysts is relatively small (~4).
Links for more information: Yahoo Finance Company Profile | MarketBeat Competitors | UFP Technologies Official Site
Interpretation: As a CDMO (contract development and manufacturing organization), UFP likely serves OEMs and Tier 1 suppliers rather than end consumers; medical segment appears to be the growth driver based on recent commentary.
Limitation: Specific customer names or revenue concentration not publicly detailed in available sources; typical for contract manufacturers to maintain confidentiality.
| Competitor | Focus Area | Notes |
|---|---|---|
| Sonoco Products (SON) | Packaging | Broader packaging solutions |
| Graphic Packaging (GPK) | Packaging | Fiber-based packaging |
| Packaging Corp of America (PKG) | Packaging | Corrugated and containerboard |
| West Pharmaceutical Services | Medical packaging/components | Drug delivery and packaging |
| Sealed Air | Protective packaging | Broader industrial/consumer |
| Integer Holdings (ITGR) | Medical device outsourcing | Larger, diversified MDO player |
| Others (e.g., Marian, Creative Foam, Essentra) | Foam/custom components | Specialized foam/fabrication competitors |
Fact: Competitors identified via market analyses include packaging giants and medical-focused firms; UFP differentiates via custom engineered solutions and recent acquisitions (e.g., Contech Medical, DAS Medical, Advant Medical, AQF Medical, Marble Medical, Welch Fluorocarbon).
Interpretation: Competition is fragmented across end-markets; medical device outsourcing space is growing but competitive with both large and niche players.
Links for more information: Yahoo Finance Profile | Wikipedia (acquisition history) | Corporate Website
UFP Technologies, Inc., together with subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products primarily in the United States. It serves medical, aerospace & defense, automotive, consumer, electronics, and industrial markets via a direct sales force. Headquartered in Newburyport, Massachusetts. ~4,846 full-time employees. Fiscal year ends December 31. Industry: Medical Devices (Healthcare sector).
Interpretation: Acquisition strategy has expanded medical capabilities and geographic/ product reach, supporting diversification and growth.
Limitation: Detailed financial impact of each acquisition or full historical revenue series requires 10-K filings; recent 2026 events include IT system suspicious activity report (Feb 2026) and multiple 8-K filings on governance/earnings.